Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of MK-3475 in Combination With BCG for Patients With High Risk Superficial Bladder Cancer

NCT02324582 is registered in ClinicalTrials.gov with Southern Illinois University as lead sponsor.

NCT NCT02324582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02324582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of MK-3475 in Combination With BCG for Patients With High Risk Superficial Bladder Cancer
Lead sponsor
Southern Illinois University
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2015
Completion date
March 27, 2023
Enrollment
18 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer